sifalimumab (MDX-1103) - AstraZeneca
Benlysta (belimumab) - GSK
blisibimod (A-623) - Anthera
Stelara (ustekinumab) - J&J
anifrolumab (MEDI-546) - AstraZeneca
Rituxan (rituximab) - Roche, Biogen
http://www.ncbi.nlm.nih.gov/pubmed/31565077
 
Oct 1, 2019
 
Prev Next